NESTA (the National Endowment for Science, Technology and the Arts) announces today an investment round worth £500,000 to commercialise an innovative new monitoring device which samples blood while it is still within the patient's body. Blood analysis is costly and labour-intensive. It relies almost exclusively on blood withdrawal and off-line analysis, requiring extensive input from professional health staff -- which inevitably leads to delays and can result in errors.

Innovations Report (http://www.innovations-report.com/html/reports/medicine_health/report-53806.html)